Immuron (IMRN) Equity Income (2022 - 2024)
Immuron (IMRN) posted Equity Income of -$9702.0 for Q3 2024, up 98.99% on a QoQ basis from -$959552.2 in Q2 2024.
Analysis
Immuron (IMRN) Equity Income (2022 - 2024) Analysis & Trends
Immuron has reported Equity Income for 3 years, with the latest figure at -$9702.0 in Q3 2024.
- On a quarterly basis, Equity Income changed N/A year-over-year to -$9702.0 in Q3 2024; TTM through Sep 2024 was -$1.3 million, a N/A change from a year earlier, with the FY2024 full-year figure at -$14560.2, up 92.82% from the prior year.
- Equity Income was -$9702.0 for Q3 2024 at Immuron, up from -$959552.2 in the prior quarter.
- The five-year high for Equity Income was -$9702.0 in Q3 2024, with the low at -$959552.2 in Q2 2024.
- Average Equity Income over 3 years is -$318033.1, with a median of -$151439.1 recorded in 2023.
- The largest YoY upside for Equity Income was 130.16% in 2023 against a maximum downside of 130.16% in 2023.
- Over 3 years, Equity Income stood at -$91736.0 in 2022, then plunged by 130.16% to -$211142.3 in 2023, then surged by 95.41% to -$9702.0 in 2024.
- The last three Equity Income figures came in at -$9702.0 (Q3 2024), -$959552.2 (Q2 2024), and -$211142.3 (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | - |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | - |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | - |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | - |
| 10 | Immuron | 7.14 Mn | -1.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 9, 2024 | -9,701.96 |
| Jun 30, 2024 | -959,552.17 |
| Dec 31, 2023 | -211,142.25 |
| Dec 31, 2022 | -91,736.00 |